Table 1.
Recommended | Recommended if acquired/if present | Optional | |
---|---|---|---|
Administrative |
Site of service Scanner |
N/A |
Site ID Accreditation entity and status |
Demographics |
Unique patient ID Patient date of birth (DOB) or age in years Patient sex Reasons for limited examinations Summary of test findings Physician signature and date (electronic signature and date must be clearly labeled) Adequate description of test |
Comparison with previous related studies | Patient Race/Ethnicity |
Study referral data | Referring physician | N/A |
Referring physician provider number Referring physician specialty |
Scheduling and performance of study |
Date of procedure Personnel involved in procedure |
N/A | Time of procedure |
Listing of sequences used |
Black-blood Late gadolinium enhancement (LGE) Edema Cine Strain Perfusion Flow Iron MR angiography |
N/A | N/A |
History and risk factors |
Height (in or cm) Weight (lb or kg) Body surface area (BSA) Heart rate (beats per min) Rhythm Blood pressure brachial or femoral (specify which) arterial cuff systolic and diastolic blood pressure (mmHg) |
For studies using contrast agents, value and date of the most recent serum creatinine and estimated glomerular filtration rate (eGFR) | N/A |
Non-imaging findings associated with examinations | |||
Studies requiring 12-lead electrocardiogram |
Interpretation Rhythm Ventricular rate Presence of Q-waves ST segment T-wave abnormalities |
N/A | N/A |
Tests incorporation stress testing |
Heart rates and rhythm Oxygen saturation Maximum predicted heart rate response for age Each should be recorded during following points in time and more frequently as clinically indicated: at pre-test baseline, at each level of stress, after recovery |
N/A | Systolic and diastolic blood pressures |
Studies utilizing vasoactive or positive inotrope pharmacological cardioactive agents |
Type of agent Quantity of agent Duration of agent Route of administration Associated medications and presence/absence of any side effects |
N/A | N/A |
Studies utilizing contrast agents |
Type and name of contrast agent Volume of agent Route of administration Dosage of agent and presence/absence of any side effects |
N/A | N/A |
Studies utilizing sedation |
General anesthesia Continuous display (hemodynamic or electric) Recording of heart rate and rhythm and/or blood pressure Type, volume, route of administration Any side effects Patient’s cardiovascular and pulmonary response Reason for administration |
N/A | N/A |
Reporting criteria for CMR examinations |
Standardized report format agreed upon in facility Final report reviewed by interpreting member of medical staff Final interpretations verified and signed by medical staff (manual or electronic) within 2 business days of study for routine studies, but reported on the same day for patients referred for major acute issues Permanent record of interpretation Defined mechanism whereby results which demonstrate urgent or life-threatening findings are communicated to appropriate healthcare professionals |
If preliminary reports are issued, preliminary nature must be indicated | N/A |